Tesla Granted U.S. Patent; Analysts Optimistic On Ulta Beauty, Roblox, and Alight
- June 13th, 2023
- 530 views
Tesla, Inc. (Nasdaq: TSLA), a renowned electric vehicle and clean energy company, has been awarded U.S. Patent No. US 11,675,358 B2 by The United States Patent and Trademark Office (USPTO).
This patent, titled "Autonomous driving system emergency signaling," showcases Tesla's continued dedication to enhancing safety and innovation in autonomous driving technology.
$TSLA is trading at $252.08 in pre-market, reflecting a modest increase of $2.25 (+0.90%)
Ulta Beauty, Inc. (Nasdaq: ULTA), a leading beauty retailer offering a wide range of cosmetics, skincare, and haircare products, has received an upgrade from Hold to Buy by Loop Capital. The price target has also been raised from $490 to $520.
With $ULTA closing at $424.91 on Monday, this adjusted price target suggests a potential upside of $95.09 or 22.38%, according to Loop Capital's assessment.
Roblox Corporation (NYSE: RBLX), a popular online platform for creating and playing games, has been initiated with a Buy rating by Canaccord Genuity, setting a price target of $48.
Considering that $RBLX closed at $38.95 on Monday, the price target implies a potential upside of $9.05 or 23.22%, based on Canaccord Genuity's analysis.
Alight, Inc. (NYSE: ALIT), a leading provider of cloud-based human capital and business process outsourcing solutions, has been initiated with a Buy rating by Citigroup, establishing a price target of $12.
Based on Monday's closing price of $8.96, the price target indicates a potential upside of $3.04 or 33.93% for $ALIT, as per Citigroup's evaluation.
These potential upsides reflect the views and assessments of Loop Capital, Canaccord Genuity, and Citigroup, considering various factors and market conditions. Investors should exercise caution and conduct their own analysis before making any investment decisions.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025




Member Login